nodes	percent_of_prediction	percent_of_DWPC	metapath
Cytarabine—Gemcitabine—pancreatic cancer	0.22	1	CrCtD
Cytarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—pancreatic cancer	0.16	0.515	CiPCiCtD
Cytarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—pancreatic cancer	0.15	0.485	CiPCiCtD
Cytarabine—SLC29A1—pancreatic cancer	0.138	1	CbGaD
Cytarabine—Lamivudine—Gemcitabine—pancreatic cancer	0.0486	0.38	CrCrCtD
Cytarabine—POLD1—Gemcitabine—pancreatic cancer	0.0438	0.251	CbGbCtD
Cytarabine—Zalcitabine—Gemcitabine—pancreatic cancer	0.042	0.328	CrCrCtD
Cytarabine—POLE—Gemcitabine—pancreatic cancer	0.0317	0.181	CbGbCtD
Cytarabine—CDA—Gemcitabine—pancreatic cancer	0.0252	0.144	CbGbCtD
Cytarabine—Azacitidine—Gemcitabine—pancreatic cancer	0.0192	0.15	CrCrCtD
Cytarabine—Decitabine—Gemcitabine—pancreatic cancer	0.0183	0.143	CrCrCtD
Cytarabine—POLA1—Gemcitabine—pancreatic cancer	0.0182	0.104	CbGbCtD
Cytarabine—SLC29A1—Gemcitabine—pancreatic cancer	0.0121	0.0692	CbGbCtD
Cytarabine—DCK—Gemcitabine—pancreatic cancer	0.0112	0.0641	CbGbCtD
Cytarabine—SLC29A1—Fluorouracil—pancreatic cancer	0.0103	0.0592	CbGbCtD
Cytarabine—ABCC10—Gemcitabine—pancreatic cancer	0.00924	0.0529	CbGbCtD
Cytarabine—ABCC10—Docetaxel—pancreatic cancer	0.00604	0.0345	CbGbCtD
Cytarabine—ABCC10—Doxorubicin—pancreatic cancer	0.0045	0.0257	CbGbCtD
Cytarabine—POLB—islet of Langerhans—pancreatic cancer	0.000716	0.134	CbGeAlD
Cytarabine—CYP3A4—Tamoxifen—pancreatic cancer	0.000599	0.00342	CbGbCtD
Cytarabine—DCTD—islet of Langerhans—pancreatic cancer	0.000577	0.108	CbGeAlD
Cytarabine—CYP3A4—Erlotinib—pancreatic cancer	0.000509	0.00291	CbGbCtD
Cytarabine—POLB—pancreas—pancreatic cancer	0.000503	0.0943	CbGeAlD
Cytarabine—CYP3A4—Irinotecan—pancreatic cancer	0.00046	0.00263	CbGbCtD
Cytarabine—POLD1—pancreas—pancreatic cancer	0.000411	0.077	CbGeAlD
Cytarabine—DCTD—pancreas—pancreatic cancer	0.000406	0.076	CbGeAlD
Cytarabine—POLD1—digestive system—pancreatic cancer	0.000351	0.0658	CbGeAlD
Cytarabine—DCTD—digestive system—pancreatic cancer	0.000346	0.0649	CbGeAlD
Cytarabine—CYP3A4—Docetaxel—pancreatic cancer	0.000337	0.00193	CbGbCtD
Cytarabine—CYP3A4—Sunitinib—pancreatic cancer	0.000335	0.00192	CbGbCtD
Cytarabine—NT5E—pancreas—pancreatic cancer	0.000314	0.0588	CbGeAlD
Cytarabine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.000264	0.416	CbGdCrCtD
Cytarabine—POLE—digestive system—pancreatic cancer	0.000262	0.0492	CbGeAlD
Cytarabine—CYP3A4—Doxorubicin—pancreatic cancer	0.000251	0.00144	CbGbCtD
Cytarabine—SLC29A1—islet of Langerhans—pancreatic cancer	0.000243	0.0456	CbGeAlD
Cytarabine—Fludarabine—SLC29A1—pancreatic cancer	0.000239	0.194	CrCbGaD
Cytarabine—Ribavirin—SLC29A1—pancreatic cancer	0.000237	0.192	CrCbGaD
Cytarabine—DCK—islet of Langerhans—pancreatic cancer	0.000232	0.0435	CbGeAlD
Cytarabine—Zalcitabine—SLC29A1—pancreatic cancer	0.000229	0.186	CrCbGaD
Cytarabine—Gemcitabine—SLC29A1—pancreatic cancer	0.000226	0.183	CrCbGaD
Cytarabine—SLC29A1—pancreas—pancreatic cancer	0.000171	0.032	CbGeAlD
Cytarabine—POLD1—Azacitidine—Gemcitabine—pancreatic cancer	0.00017	0.268	CbGdCrCtD
Cytarabine—SLC22A2—digestive system—pancreatic cancer	0.000168	0.0316	CbGeAlD
Cytarabine—DCK—pancreas—pancreatic cancer	0.000163	0.0306	CbGeAlD
Cytarabine—SLC29A1—digestive system—pancreatic cancer	0.000146	0.0274	CbGeAlD
Cytarabine—DCK—digestive system—pancreatic cancer	0.000139	0.0261	CbGeAlD
Cytarabine—ABCC10—digestive system—pancreatic cancer	0.000133	0.0249	CbGeAlD
Cytarabine—Glucosamine—MMP9—pancreatic cancer	9.68e-05	0.0785	CrCbGaD
Cytarabine—DCK—Clomifene—Tamoxifen—pancreatic cancer	8.14e-05	0.128	CbGdCrCtD
Cytarabine—Gemcitabine—TYMS—pancreatic cancer	8.04e-05	0.0652	CrCbGaD
Cytarabine—Glucosamine—TNF—pancreatic cancer	6.36e-05	0.0516	CrCbGaD
Cytarabine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	6.21e-05	0.0978	CbGdCrCtD
Cytarabine—Adenosine monophosphate—SRC—pancreatic cancer	6.14e-05	0.0498	CrCbGaD
Cytarabine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	5.75e-05	0.0905	CbGdCrCtD
Cytarabine—CYP3A4—digestive system—pancreatic cancer	5.42e-05	0.0102	CbGeAlD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.11e-05	0.000983	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	2.11e-05	0.000983	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	2.01e-05	0.000934	CbGpPWpGaD
Cytarabine—CDA—Metabolism—ARG2—pancreatic cancer	2.01e-05	0.000933	CbGpPWpGaD
Cytarabine—POLA1—DNA Replication—RB1—pancreatic cancer	2e-05	0.000933	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	1.97e-05	0.000916	CbGpPWpGaD
Cytarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.95e-05	0.000908	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—CD44—pancreatic cancer	1.94e-05	0.000905	CbGpPWpGaD
Cytarabine—POLE—G1 to S cell cycle control—TP53—pancreatic cancer	1.93e-05	0.000899	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	1.93e-05	0.000899	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—RB1—pancreatic cancer	1.93e-05	0.000898	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TYMP—pancreatic cancer	1.92e-05	0.000892	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.91e-05	0.000889	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	1.89e-05	0.000881	CbGpPWpGaD
Cytarabine—POLD1—S Phase—CCND1—pancreatic cancer	1.89e-05	0.00088	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	1.88e-05	0.000876	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—GCG—pancreatic cancer	1.86e-05	0.000867	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.85e-05	0.000861	CbGpPWpGaD
Cytarabine—POLE—S Phase—CCND1—pancreatic cancer	1.83e-05	0.00085	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.82e-05	0.000846	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—STK11—pancreatic cancer	1.75e-05	0.000815	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TYMP—pancreatic cancer	1.75e-05	0.000815	CbGpPWpGaD
Cytarabine—POLA1—S Phase—RB1—pancreatic cancer	1.75e-05	0.000815	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.72e-05	0.000801	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	1.72e-05	0.000799	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	1.7e-05	0.000789	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—PPP2R5B—pancreatic cancer	1.69e-05	0.000788	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	1.69e-05	0.000786	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—RB1—pancreatic cancer	1.63e-05	0.000757	CbGpPWpGaD
Cytarabine—POLE—G1/S Transition—MYC—pancreatic cancer	1.61e-05	0.000751	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	1.61e-05	0.000747	CbGpPWpGaD
Cytarabine—POLE—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	1.59e-05	0.000739	CbGpPWpGaD
Cytarabine—POLA1—E2F transcription factor network—MYC—pancreatic cancer	1.59e-05	0.000737	CbGpPWpGaD
Cytarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	1.55e-05	0.000719	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GLP1R—pancreatic cancer	1.54e-05	0.000719	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—DPYD—pancreatic cancer	1.52e-05	0.000707	CbGpPWpGaD
Cytarabine—POLD1—S Phase—MYC—pancreatic cancer	1.52e-05	0.000706	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—FOXM1—pancreatic cancer	1.51e-05	0.000703	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—TYMS—pancreatic cancer	1.51e-05	0.000701	CbGpPWpGaD
Cytarabine—POLE—S Phase—MYC—pancreatic cancer	1.47e-05	0.000682	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—SLC2A2—pancreatic cancer	1.44e-05	0.000671	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PRSS1—pancreatic cancer	1.43e-05	0.000667	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	1.43e-05	0.000665	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GLP1R—pancreatic cancer	1.41e-05	0.000657	CbGpPWpGaD
Cytarabine—CDA—Metabolism—DPYD—pancreatic cancer	1.39e-05	0.000647	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.38e-05	0.000641	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	1.38e-05	0.000641	CbGpPWpGaD
Cytarabine—POLE—Mitotic G1-G1/S phases—MYC—pancreatic cancer	1.36e-05	0.000633	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PRSS1—pancreatic cancer	1.35e-05	0.000628	CbGpPWpGaD
Cytarabine—CDA—Metabolism—SLC2A2—pancreatic cancer	1.32e-05	0.000614	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.32e-05	0.000614	CbGpPWpGaD
Cytarabine—POLA1—S Phase—CCND1—pancreatic cancer	1.3e-05	0.000606	CbGpPWpGaD
Cytarabine—SLC22A2—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	1.28e-05	0.000596	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—TYMS—pancreatic cancer	1.28e-05	0.000595	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—ARG2—pancreatic cancer	1.24e-05	0.000579	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—TYMS—pancreatic cancer	1.24e-05	0.000575	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—APOE—pancreatic cancer	1.23e-05	0.00057	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	1.21e-05	0.000562	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—BRCA2—pancreatic cancer	1.2e-05	0.000559	CbGpPWpGaD
Cytarabine—SLC22A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	1.19e-05	0.000555	CbGpPWpGaD
Cytarabine—DCK—Metabolism—ARG2—pancreatic cancer	1.17e-05	0.000544	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—BRCA2—pancreatic cancer	1.16e-05	0.00054	CbGpPWpGaD
Cytarabine—POLA1—G1/S Transition—MYC—pancreatic cancer	1.15e-05	0.000535	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TYMS—pancreatic cancer	1.14e-05	0.000532	CbGpPWpGaD
Cytarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	1.13e-05	0.000526	CbGpPWpGaD
Cytarabine—POLE—Mitotic M-M/G1 phases—RB1—pancreatic cancer	1.12e-05	0.000521	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—CD44—pancreatic cancer	1.12e-05	0.00052	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CG—pancreatic cancer	1.11e-05	0.000515	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TYMS—pancreatic cancer	1.1e-05	0.000514	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TYMP—pancreatic cancer	1.09e-05	0.000506	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—GCG—pancreatic cancer	1.07e-05	0.000498	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PPARG—pancreatic cancer	1.07e-05	0.000497	CbGpPWpGaD
Cytarabine—POLA1—S Phase—MYC—pancreatic cancer	1.04e-05	0.000486	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TYMP—pancreatic cancer	1.02e-05	0.000476	CbGpPWpGaD
Cytarabine—CDA—Metabolism—CD44—pancreatic cancer	1.02e-05	0.000475	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	1.01e-05	0.000471	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—STK11—pancreatic cancer	1.01e-05	0.000468	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TERT—pancreatic cancer	9.96e-06	0.000463	CbGpPWpGaD
Cytarabine—CDA—Metabolism—GCG—pancreatic cancer	9.79e-06	0.000456	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CD—pancreatic cancer	9.73e-06	0.000453	CbGpPWpGaD
Cytarabine—POLA1—Mitotic G1-G1/S phases—MYC—pancreatic cancer	9.69e-06	0.000451	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TERT—pancreatic cancer	9.62e-06	0.000448	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	9.41e-06	0.000438	CbGpPWpGaD
Cytarabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	9.33e-06	0.000434	CbGpPWpGaD
Cytarabine—CDA—Metabolism—STK11—pancreatic cancer	9.21e-06	0.000428	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	9.15e-06	0.000426	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	9.07e-06	0.000422	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	8.84e-06	0.000411	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—TYMS—pancreatic cancer	8.8e-06	0.000409	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GLP1R—pancreatic cancer	8.76e-06	0.000408	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—RB1—pancreatic cancer	8.67e-06	0.000403	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—TYMS—pancreatic cancer	8.66e-06	0.000403	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—DPYD—pancreatic cancer	8.62e-06	0.000401	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CB—pancreatic cancer	8.48e-06	0.000395	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTGS2—pancreatic cancer	8.4e-06	0.000391	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—RB1—pancreatic cancer	8.37e-06	0.00039	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—BRCA2—pancreatic cancer	8.27e-06	0.000385	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GLP1R—pancreatic cancer	8.24e-06	0.000383	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	8.19e-06	0.000381	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—SLC2A2—pancreatic cancer	8.18e-06	0.000381	CbGpPWpGaD
Cytarabine—DCK—Metabolism—DPYD—pancreatic cancer	8.11e-06	0.000377	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	7.98e-06	0.000371	CbGpPWpGaD
Cytarabine—POLA1—Mitotic M-M/G1 phases—RB1—pancreatic cancer	7.98e-06	0.000371	CbGpPWpGaD
Cytarabine—CDA—Metabolism—TYMS—pancreatic cancer	7.92e-06	0.000368	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TYMS—pancreatic cancer	7.87e-06	0.000366	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—RB1—pancreatic cancer	7.75e-06	0.000361	CbGpPWpGaD
Cytarabine—DCK—Metabolism—SLC2A2—pancreatic cancer	7.69e-06	0.000358	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	7.62e-06	0.000355	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—RB1—pancreatic cancer	7.49e-06	0.000348	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	7.36e-06	0.000342	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	7.34e-06	0.000342	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PTEN—pancreatic cancer	7.33e-06	0.000341	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	7.33e-06	0.000341	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	7.18e-06	0.000334	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—APOE—pancreatic cancer	7.04e-06	0.000328	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TERT—pancreatic cancer	6.86e-06	0.000319	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.84e-06	0.000318	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CDKN2A—pancreatic cancer	6.82e-06	0.000317	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.78e-06	0.000316	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CDKN2A—pancreatic cancer	6.58e-06	0.000306	CbGpPWpGaD
Cytarabine—SLC22A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.51e-06	0.000303	CbGpPWpGaD
Cytarabine—CDA—Metabolism—APOE—pancreatic cancer	6.44e-06	0.0003	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	6.44e-06	0.0003	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CG—pancreatic cancer	6.36e-06	0.000296	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—CD44—pancreatic cancer	6.34e-06	0.000295	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.23e-06	0.00029	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—CCND1—pancreatic cancer	6.22e-06	0.000289	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PPARG—pancreatic cancer	6.14e-06	0.000285	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—GCG—pancreatic cancer	6.08e-06	0.000283	CbGpPWpGaD
Cytarabine—SLC22A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.06e-06	0.000282	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	6.03e-06	0.000281	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—RB1—pancreatic cancer	5.97e-06	0.000278	CbGpPWpGaD
Cytarabine—DCK—Metabolism—CD44—pancreatic cancer	5.96e-06	0.000277	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CG—pancreatic cancer	5.81e-06	0.00027	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—CCND1—pancreatic cancer	5.76e-06	0.000268	CbGpPWpGaD
Cytarabine—DCK—Metabolism—GCG—pancreatic cancer	5.71e-06	0.000266	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—STK11—pancreatic cancer	5.71e-06	0.000266	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PPARG—pancreatic cancer	5.61e-06	0.000261	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CD—pancreatic cancer	5.59e-06	0.00026	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—CCND1—pancreatic cancer	5.56e-06	0.000259	CbGpPWpGaD
Cytarabine—DCK—Metabolism—STK11—pancreatic cancer	5.37e-06	0.00025	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PRSS1—pancreatic cancer	5.34e-06	0.000249	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—RB1—pancreatic cancer	5.34e-06	0.000248	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	5.25e-06	0.000244	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—PIK3CA—pancreatic cancer	5.17e-06	0.00024	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle, Mitotic—MYC—pancreatic cancer	5.17e-06	0.00024	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CD—pancreatic cancer	5.11e-06	0.000238	CbGpPWpGaD
Cytarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	5.09e-06	0.000237	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle, Mitotic—MYC—pancreatic cancer	4.99e-06	0.000232	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PRSS1—pancreatic cancer	4.98e-06	0.000232	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—TYMS—pancreatic cancer	4.91e-06	0.000229	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CB—pancreatic cancer	4.87e-06	0.000227	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTGS2—pancreatic cancer	4.83e-06	0.000225	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CDKN2A—pancreatic cancer	4.69e-06	0.000218	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—ARG2—pancreatic cancer	4.63e-06	0.000215	CbGpPWpGaD
Cytarabine—DCK—Metabolism—TYMS—pancreatic cancer	4.62e-06	0.000215	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—MYC—pancreatic cancer	4.62e-06	0.000215	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—MYC—pancreatic cancer	4.46e-06	0.000208	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CB—pancreatic cancer	4.45e-06	0.000207	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	4.43e-06	0.000206	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTGS2—pancreatic cancer	4.41e-06	0.000205	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—ARG2—pancreatic cancer	4.32e-06	0.000201	CbGpPWpGaD
Cytarabine—DCTD—Metabolism—AKT1—pancreatic cancer	4.22e-06	0.000196	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PTEN—pancreatic cancer	4.21e-06	0.000196	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMP—pancreatic cancer	4.05e-06	0.000188	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—APOE—pancreatic cancer	4e-06	0.000186	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—CCND1—pancreatic cancer	3.96e-06	0.000184	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PTEN—pancreatic cancer	3.85e-06	0.000179	CbGpPWpGaD
Cytarabine—POLD1—Cell Cycle—TP53—pancreatic cancer	3.79e-06	0.000176	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMP—pancreatic cancer	3.77e-06	0.000176	CbGpPWpGaD
Cytarabine—DCK—Metabolism—APOE—pancreatic cancer	3.76e-06	0.000175	CbGpPWpGaD
Cytarabine—POLE—Cell Cycle—TP53—pancreatic cancer	3.66e-06	0.00017	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CG—pancreatic cancer	3.61e-06	0.000168	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle, Mitotic—MYC—pancreatic cancer	3.55e-06	0.000165	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PPARG—pancreatic cancer	3.48e-06	0.000162	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CG—pancreatic cancer	3.39e-06	0.000158	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PPARG—pancreatic cancer	3.27e-06	0.000152	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GLP1R—pancreatic cancer	3.26e-06	0.000152	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—DPYD—pancreatic cancer	3.21e-06	0.000149	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—MYC—pancreatic cancer	3.18e-06	0.000148	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CD—pancreatic cancer	3.17e-06	0.000147	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—SLC2A2—pancreatic cancer	3.05e-06	0.000142	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GLP1R—pancreatic cancer	3.04e-06	0.000142	CbGpPWpGaD
Cytarabine—SLC22A2—Transmission across Chemical Synapses—HRAS—pancreatic cancer	3.01e-06	0.00014	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—DPYD—pancreatic cancer	2.99e-06	0.000139	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CD—pancreatic cancer	2.98e-06	0.000139	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—PIK3CA—pancreatic cancer	2.97e-06	0.000138	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—SLC2A2—pancreatic cancer	2.84e-06	0.000132	CbGpPWpGaD
Cytarabine—SLC22A1—Transmission across Chemical Synapses—HRAS—pancreatic cancer	2.8e-06	0.00013	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CB—pancreatic cancer	2.76e-06	0.000129	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTGS2—pancreatic cancer	2.74e-06	0.000127	CbGpPWpGaD
Cytarabine—CDA—Metabolism—PIK3CA—pancreatic cancer	2.72e-06	0.000126	CbGpPWpGaD
Cytarabine—POLA1—Cell Cycle—TP53—pancreatic cancer	2.61e-06	0.000121	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CB—pancreatic cancer	2.6e-06	0.000121	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTGS2—pancreatic cancer	2.57e-06	0.00012	CbGpPWpGaD
Cytarabine—NT5E—Metabolism—AKT1—pancreatic cancer	2.43e-06	0.000113	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PTEN—pancreatic cancer	2.39e-06	0.000111	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—CD44—pancreatic cancer	2.36e-06	0.00011	CbGpPWpGaD
Cytarabine—SLC22A2—Neuronal System—HRAS—pancreatic cancer	2.3e-06	0.000107	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—GCG—pancreatic cancer	2.26e-06	0.000105	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PTEN—pancreatic cancer	2.25e-06	0.000104	CbGpPWpGaD
Cytarabine—CDA—Metabolism—AKT1—pancreatic cancer	2.22e-06	0.000103	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—CD44—pancreatic cancer	2.2e-06	0.000102	CbGpPWpGaD
Cytarabine—SLC22A1—Neuronal System—HRAS—pancreatic cancer	2.15e-06	9.99e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—STK11—pancreatic cancer	2.13e-06	9.89e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—GCG—pancreatic cancer	2.11e-06	9.81e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—STK11—pancreatic cancer	1.98e-06	9.22e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—TYMS—pancreatic cancer	1.83e-06	8.51e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	1.8e-06	8.37e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—TYMS—pancreatic cancer	1.71e-06	7.93e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—PIK3CA—pancreatic cancer	1.68e-06	7.84e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—PIK3CA—pancreatic cancer	1.58e-06	7.37e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—ARG2—pancreatic cancer	1.56e-06	7.25e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—APOE—pancreatic cancer	1.49e-06	6.92e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—APOE—pancreatic cancer	1.39e-06	6.45e-05	CbGpPWpGaD
Cytarabine—POLD1—Metabolism—AKT1—pancreatic cancer	1.38e-06	6.4e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMP—pancreatic cancer	1.36e-06	6.34e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CG—pancreatic cancer	1.34e-06	6.25e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PPARG—pancreatic cancer	1.3e-06	6.03e-05	CbGpPWpGaD
Cytarabine—DCK—Metabolism—AKT1—pancreatic cancer	1.29e-06	6.02e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CG—pancreatic cancer	1.25e-06	5.82e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PPARG—pancreatic cancer	1.21e-06	5.62e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CD—pancreatic cancer	1.18e-06	5.49e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CD—pancreatic cancer	1.1e-06	5.12e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.1e-06	5.11e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.08e-06	5.03e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CB—pancreatic cancer	1.03e-06	4.79e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.03e-06	4.77e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTGS2—pancreatic cancer	1.02e-06	4.74e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CB—pancreatic cancer	9.59e-07	4.46e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTGS2—pancreatic cancer	9.5e-07	4.42e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PTEN—pancreatic cancer	8.89e-07	4.14e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PTEN—pancreatic cancer	8.29e-07	3.86e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—CD44—pancreatic cancer	7.94e-07	3.69e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—GCG—pancreatic cancer	7.61e-07	3.54e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—STK11—pancreatic cancer	7.16e-07	3.33e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—PIK3CA—pancreatic cancer	6.27e-07	2.92e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—TYMS—pancreatic cancer	6.16e-07	2.86e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—PIK3CA—pancreatic cancer	5.85e-07	2.72e-05	CbGpPWpGaD
Cytarabine—SLC22A2—Metabolism—AKT1—pancreatic cancer	5.12e-07	2.38e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—APOE—pancreatic cancer	5.01e-07	2.33e-05	CbGpPWpGaD
Cytarabine—SLC22A1—Metabolism—AKT1—pancreatic cancer	4.78e-07	2.22e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	4.52e-07	2.1e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PPARG—pancreatic cancer	4.36e-07	2.03e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	3.97e-07	1.85e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	3.46e-07	1.61e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	3.43e-07	1.6e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PTEN—pancreatic cancer	2.99e-07	1.39e-05	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	2.11e-07	9.82e-06	CbGpPWpGaD
Cytarabine—CYP3A4—Metabolism—AKT1—pancreatic cancer	1.72e-07	8.02e-06	CbGpPWpGaD
